Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype.

Engmann L, Jin S, Sun F, Legro RS, Polotsky AJ, Hansen KR, Coutifaris C, Diamond MP, Eisenberg E, Zhang H, Santoro N; Reproductive Medicine Network.

Am J Obstet Gynecol. 2017 May;216(5):493.e1-493.e13. doi: 10.1016/j.ajog.2017.01.003. Epub 2017 Jan 16.

PMID:
28104402
2.

Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes.

Steiner AZ, Diamond MP, Legro RS, Schlaff WD, Barnhart KT, Casson PR, Christman GM, Alvero R, Hansen KR, Geisler WM, Thomas T, Santoro N, Zhang H, Eisenberg E; Reproductive Medicine Network.

Fertil Steril. 2015 Dec;104(6):1522-6. doi: 10.1016/j.fertnstert.2015.08.022. Epub 2015 Sep 25.

3.

Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility.

Diamond MP, Legro RS, Coutifaris C, Alvero R, Robinson RD, Casson P, Christman GM, Ager J, Huang H, Hansen KR, Baker V, Usadi R, Seungdamrong A, Bates GW, Rosen RM, Haisenleder D, Krawetz SA, Barnhart K, Trussell JC, Ohl D, Jin Y, Santoro N, Eisenberg E, Zhang H; NICHD Reproductive Medicine Network.

N Engl J Med. 2015 Sep 24;373(13):1230-40. doi: 10.1056/NEJMoa1414827.

4.

Predictors of participant retention in infertility treatment trials.

Kuang H, Jin S, Thomas T, Engmann L, Hansen KR, Coutifaris C, Casson P, Christman G, Alvero R, Santoro N, Eisenberg E, Diamond MP, Legro RS, Zhang H; Reproductive Medicine Network.

Fertil Steril. 2015 Nov;104(5):1236-43.e1-2. doi: 10.1016/j.fertnstert.2015.08.001. Epub 2015 Sep 3.

5.

Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome.

Kuang H, Jin S, Hansen KR, Diamond MP, Coutifaris C, Casson P, Christman G, Alvero R, Huang H, Bates GW, Usadi R, Lucidi S, Baker V, Santoro N, Eisenberg E, Legro RS, Zhang H; Reproductive Medicine Network.

Hum Reprod. 2015 Sep;30(9):2222-33. doi: 10.1093/humrep/dev182. Epub 2015 Jul 22.

6.

Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics.

Diamond MP, Legro RS, Coutifaris C, Alvero R, Robinson RD, Casson P, Christman GM, Ager J, Huang H, Hansen KR, Baker V, Usadi R, Seungdamrong A, Bates GW, Rosen RM, Haisonleder D, Krawetz SA, Barnhart K, Trussell JC, Jin Y, Santoro N, Eisenberg E, Zhang H; National Institute of Child Health and Human Development (NICHD) Reproductive Medicine Network.

Fertil Steril. 2015 Apr;103(4):962-973.e4. doi: 10.1016/j.fertnstert.2014.12.130. Epub 2015 Feb 20.

7.

Letrozole versus clomiphene for infertility in the polycystic ovary syndrome.

Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, Christman GM, Huang H, Yan Q, Alvero R, Haisenleder DJ, Barnhart KT, Bates GW, Usadi R, Lucidi S, Baker V, Trussell JC, Krawetz SA, Snyder P, Ohl D, Santoro N, Eisenberg E, Zhang H; NICHD Reproductive Medicine Network.

N Engl J Med. 2014 Jul 10;371(2):119-29. doi: 10.1056/NEJMoa1313517. Erratum in: N Engl J Med. 2014 Oct 9;317(15):1465.

8.

The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome.

Legro RS, Kunselman AR, Brzyski RG, Casson PR, Diamond MP, Schlaff WD, Christman GM, Coutifaris C, Taylor HS, Eisenberg E, Santoro N, Zhang H; NICHD Reproductive Medicine Network.

Contemp Clin Trials. 2012 May;33(3):470-81. doi: 10.1016/j.cct.2011.12.005. Epub 2012 Jan 13.

9.

Aprotinin and lysine analogues in high-risk cardiac surgery.

Porte RJ, Mallette SV, Burroughs AK.

N Engl J Med. 2008 Sep 11;359(11):1181; author reply 1181-2. doi: 10.1056/NEJMc081370. No abstract available.

10.

The integrative clinical preceptor model: a new method for teaching undergraduate community health nursing.

Mallette S, Loury S, Engelke MK, Andrews A.

Nurse Educ. 2005 Jan-Feb;30(1):21-6.

PMID:
15685021
11.

Requirement for protein kinase C activation in basic fibroblast growth factor-induced human endothelial cell proliferation.

Kent KC, Mii S, Harrington EO, Chang JD, Mallette S, Ware JA.

Circ Res. 1995 Aug;77(2):231-8.

12.

Effect of angiotensin II on human vascular smooth muscle cell growth.

Mii S, Ware JA, Mallette SA, Kent KC.

J Surg Res. 1994 Jul;57(1):174-8.

PMID:
8041134
13.

Clinical experience with Tc-99m labeled (N2S2) anti-melanoma antibody fragments and single photon emission computed tomography.

Wahl RL, Swanson NA, Johnson JW, Natale R, Petry NA, Mallette S, Kasina S, Reno J, Sullivan K, Abrams P.

Am J Physiol Imaging. 1992 Apr-Jun;7(2):48-58.

PMID:
1419120
14.

Treatment of neuroblastoma with [125I]metaiodobenzylguanidine.

Sisson JC, Shapiro B, Hutchinson RJ, Zasadny KR, Mallette S, Mudgett EE, Wieland DM.

J Nucl Biol Med. 1991 Oct-Dec;35(4):255-9.

PMID:
1823830
15.

Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography.

Schwaiger M, Hutchins GD, Kalff V, Rosenspire K, Haka MS, Mallette S, Deeb GM, Abrams GD, Wieland D.

J Clin Invest. 1991 May;87(5):1681-90.

16.

Iodine-125-MIBG to treat neuroblastoma: preliminary report.

Sisson JC, Hutchinson RJ, Shapiro B, Zasadny KR, Normolle D, Wieland DM, Wahl RL, Singer DA, Mallette SA, Mudgett EE.

J Nucl Med. 1990 Sep;31(9):1479-85.

17.

Lymphoscintigraphy in melanoma: initial evaluation of a low protein dose monoclonal antibody cocktail.

Wahl RL, Liebert M, Headington J, Wilson BS, Shulkin BL, Johnson JW, Mallette S, Natale RB, Coon W, East M, et al.

Cancer Res. 1990 Feb 1;50(3 Suppl):941s-948s.

18.

Calculating radiation absorbed dose for pheochromocytoma tumors in 131-I MIBG therapy.

Koral KF, Wang XH, Sisson JC, Botti J, Meyer L, Mallette S, Glazer GM, Adler RS.

Int J Radiat Oncol Biol Phys. 1989 Jul;17(1):211-8.

PMID:
2787315
19.

Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.

Khafagi FA, Shapiro B, Fig LM, Mallette S, Sisson JC.

J Nucl Med. 1989 Apr;30(4):481-9.

20.

Toxicity from treatment of neuroblastoma with 131I-meta-iodobenzylguanidine.

Sisson JC, Hutchinson RJ, Carey JE, Shapiro B, Johnson JW, Mallette SA, Wieland DM.

Eur J Nucl Med. 1988;14(7-8):337-40.

Supplemental Content

Loading ...
Support Center